← Open Payments lookup

NATALIE VATINYAN: Open Payments

NPI 1902663842 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,823 in 75 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,143 · 2025 $1,823

Food & beverage: $1,655Education: $168
CompanyPaymentsAmount
ABBVIE INC.34$813
Janssen Biotech, Inc.6$245
Ardelyx, Inc.10$177
Regeneron Healthcare Solutions, Inc.4$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$72
Takeda Pharmaceuticals U.S.A., Inc.2$60
Phathom Pharmaceuticals, Inc.3$58
Lilly USA, LLC2$51
Madrigal Pharmaceuticals1$36
EVOKE PHARMA, INC.2$34

Products named: RINVOQ, SKYRIZI, IBSRELA, TREMFYA, DUPIXENT, CREON, STELARA, XIFAXAN.

Industry payments across TX — which companies pay providers there.